Verapamil and pulmonary hypertension. 1978

K Landmark, and A M Refsum, and S Simonsen, and O Storstein

We report on the effect of verapamil in 12 patients suffering from pulmonary hypertension. The drug caused a slight, but statistically significant decrease in mean pulmonary artery pressure and in the work performance by the right ventricle. The mean pressure of the right atrium, the end-diastolic pressure of the right ventricle, the pulmonary arteriolar resistance, the cardiac index and the stroke volume were not significantly changed, however, and there was a wide spread of the values observed. In some patients the drug exerted a marked negative inotropic effect, with a concomitant increase in the pulmonary arteriolar resistance.

UI MeSH Term Description Entries
D006976 Hypertension, Pulmonary Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES. Pulmonary Hypertension
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009200 Myocardial Contraction Contractile activity of the MYOCARDIUM. Heart Contractility,Inotropism, Cardiac,Cardiac Inotropism,Cardiac Inotropisms,Contractilities, Heart,Contractility, Heart,Contraction, Myocardial,Contractions, Myocardial,Heart Contractilities,Inotropisms, Cardiac,Myocardial Contractions
D011652 Pulmonary Circulation The circulation of the BLOOD through the LUNGS. Pulmonary Blood Flow,Respiratory Circulation,Circulation, Pulmonary,Circulation, Respiratory,Blood Flow, Pulmonary,Flow, Pulmonary Blood,Pulmonary Blood Flows
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002302 Cardiac Output The volume of BLOOD passing through the HEART per unit of time. It is usually expressed as liters (volume) per minute so as not to be confused with STROKE VOLUME (volume per beat). Cardiac Outputs,Output, Cardiac,Outputs, Cardiac
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females

Related Publications

K Landmark, and A M Refsum, and S Simonsen, and O Storstein
January 1982, Clinical and experimental pharmacology & physiology,
K Landmark, and A M Refsum, and S Simonsen, and O Storstein
March 1985, British heart journal,
K Landmark, and A M Refsum, and S Simonsen, and O Storstein
January 1988, Cor et vasa,
K Landmark, and A M Refsum, and S Simonsen, and O Storstein
September 1977, Experientia,
K Landmark, and A M Refsum, and S Simonsen, and O Storstein
December 1994, Journal of anesthesia,
K Landmark, and A M Refsum, and S Simonsen, and O Storstein
January 1983, The American journal of cardiology,
K Landmark, and A M Refsum, and S Simonsen, and O Storstein
January 1986, Clinical and investigative medicine. Medecine clinique et experimentale,
K Landmark, and A M Refsum, and S Simonsen, and O Storstein
July 1984, British heart journal,
K Landmark, and A M Refsum, and S Simonsen, and O Storstein
January 1988, Cor et vasa,
K Landmark, and A M Refsum, and S Simonsen, and O Storstein
January 1987, Przeglad lekarski,
Copied contents to your clipboard!